Table 3.
Independent Predictors of Having Had a Biopsy Diagnosis of NAFLD
| Attribute | Odds Ratio | 95% Confidence Interval |
|---|---|---|
| Age | 0.985 | 0.974, 0.995 |
| Sex (male vs. female) | 0.743 | 0.560, 0.985 |
| Race (non‐White vs. White) | 0.483 | 0.329, 0.709 |
| Type 2 diabetes | 1.432 | 1.073, 1.911 |
| Hyperlipidemia | 1.256 | 0.928, 1.702 |
| Anxiety/depression | 1.576 | 1.191, 2.086 |
| Autoimmune/rheumatologic conditions | 1.502 | 0.925, 2.437 |
| ALT | 1.014 | 1.011, 1.017 |
| Albumin | 1.246 | 0.971, 1.600 |
Note: A forward, step‐wise logistic regression model was fit (significance level for entry = 0.25; significance level to remain in the model = 0.1) with the following predictors of liver biopsy: age, sex, race (White vs. non‐White), BMI, type 2 diabetes, hyperlipidemia, depression/anxiety, osteoarthritis, sleep apnea, autoimmune/rheumatologic conditions, thrombocytopenia, ALT, total bilirubin, albumin, and evidence of ascites from imaging or paracentesis. Final model n = 288 biopsy within 1 year of enrollment; n = 1,709 no biopsy ever. Bold faced values are statistically significant.